Evaluation of the Effectiveness of Risk Minimisation Measures: A Survey among Health Care Professionals to Assess their Knowledge and Attitudes on Prescribing Conditions of Instanyl® in France and the Netherlands

First published 16/06/2015

Last updated 29/03/2024

EU PAS number:

EUPAS9924

Study

Finalised

Documents

Study protocol

Initial protocol

Instanyl-5001- Protocol revised-FINAL-2015-02-06-V3

English (928.64 KB - PDF)View document

Study results

Instanyl-5001 Study Report 24 Apr 2016

English (3.02 MB - PDF)View document

Study report

Other information

ENCePP Seal

ENCePP Seal documents

Secondary tabs